Debt marketplace operator CrossLend raised $38.5m in a series B round led by Santander InnoVentures at a reported valuation of more than $110m.

Invest NI is to continue its funding relationship wit Crescent Capital and Techstart Ventures, the latter of which has previously operated two $2m funds aimed at spinouts.

Woodford Patient Capital Trust has been left with only a lifeline after Neil Woodford announced the closure of his fund management firm.

The reinsurance data software provider received $12m in a round co-led by Transamerica Ventures and backed by Allianz X and Insight Catastrophe Group.

Spun out of University of Duisburg-Essen and University of Düsseldorf, Abalos has raised funding to kickstart development of arenavirus-based immunotherapies.

Intel Capital was among the participants in a round that lifted the total raised by rare disease-focused drug developer Healx to nearly $70m.

Boehringer Ingelheim Venture Fund co-led a $13.3m round for the immuno-oncoclogy startup, which was spun out of University of Duisburg-Essen’s and University of Düsseldorf.

Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

Neil Woodford has been removed as investment manager of the Equity Income Fund, which will be wound down by administrator Link Fund Solutions.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.